Shares of Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report) fell 2.3% on Wednesday . The company traded as low as $1.22 and last traded at $1.25. 707,885 shares traded hands during mid-day trading, an increase of 955% from the average session volume of 67,097 shares. The stock had previously closed at $1.28.
Cardiol Therapeutics Trading Down 2.3 %
The business has a fifty day moving average price of $1.65 and a 200 day moving average price of $1.93.
Cardiol Therapeutics Company Profile
Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.
Featured Articles
- Five stocks we like better than Cardiol Therapeutics
- Insider Trading – What You Need to Know
- S&P 500 Earnings Set to Shine: January’s Critical Market Test
- How to Calculate Options Profits
- Reddit Stock Dominated 2024—Why the Rally Isn’t Over Yet
- What is the Dogs of the Dow Strategy? Overview and Examples
- Investing in Sustainable Solutions: 2 Top Water Tech Stocks
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
